(Q74455549)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Vinata B Lokeshwar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Grethchen L Schroeder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Marie G Selzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Stefan H Hautmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Timothy Posey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Robert C Duncan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Roger Watson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lyndon Rose

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Steven Markowitz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Mark S Soloway

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

61-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

Urine based markers of urological malignancy

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

The natural history of bladder cancer. Implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Bladder cancer: state-of-the-art care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.10652

1 reference

7 January 2021

Diagnosis and management of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

The early detection and diagnosis of bladder cancer: a critical review of the options.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Bladder cancer. II. Molecular aspects and diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Can biological markers replace cystoscopy? An update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Urine cytology. It is still the gold standard for screening?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

The accuracy of urinary cytology in daily practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Biomarkers for transitional cell carcinoma-pro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Biomarkers for transitional cell carcinoma-con

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Can biological markers predict recurrence and progression of superficial bladder cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

A community study of bladder cancer screening by the detection of occult urinary bleeding.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Hematuria home screening: repeat testing results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Occupation and bladder cancer in European women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Cigar, pipe, and cigarette smoking and bladder cancer risk in European men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Filling the void: urinary markers for bladder cancer risk and diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Tumor markers in the detection of recurrent transitional cell carcinoma of the bladder: a brief review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Consecutive quantitative cytology in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Urine detection of survivin and diagnosis of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Hyaluronan: fundamental principles and applications in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Expression of hyaluronan in benign and malignant breast lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Does hyaluronan have a role in endothelial cell proliferation of the synovium?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Mechanistic studies of the effects of anti-factor H antibodies on complement-mediated lysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

HUMAN COMPLEMENT FACTOR H RELATED PROTEIN TEST FOR MONITORING BLADDER CANCER

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

An ELISA-like assay for hyaluronidase and hyaluronidase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Rising PSA after a radical treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10652

7 January 2021

Identifiers

DOI

10.1002/CNCR.10652

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference